A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Efficacy and safety of epigallocatechin-3-gallate (EGCG) in patients with cardiac amyloid light-chain (AL) amyloidosis. Evaluation of clinical efficacy of EGCG intake using a pretest posttest comparison of left ventricular amyloid mass (g/m2) measured by cardiac MRI.
Epistemonikos ID: 5ceee628e0b239f5de5973f03006303eee909ac3
First added on: May 11, 2024